Preclinical imaging of mammary intraepithelial neoplasia with positron emission tomography

被引:18
作者
Abbey, Craig K. [1 ]
Borowsky, Alexander D.
Gregg, Jeffery P.
Cardiff, Robert D.
Cherry, Simon R.
机构
[1] Univ Calif Santa Barbara, Sch Med, Dept Psychol, Santa Barbara, CA 93106 USA
[2] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA
[3] Univ Calif Davis, Dept Pathol & Lab Med, Sch Med, Davis, CA 95616 USA
[4] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA
关键词
positron emission tomography; preclinical imaging; mammary intraepithelial neoplasia; therapeutic response;
D O I
10.1007/s10911-006-9020-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Small-animal imaging with positron emission tomography (PET) has become a valuable tool for evaluating preclinical models of breast cancer and other diseases. In this review, we examine a number of issues related to preclinical imaging studies with PET, using transgenic models of ductal carcinoma in situ and metastasis as specific examples. We discuss imaging components such as reconstruction, normalization, and extraction of quantitative parameters. We also analyze the effect of longitudinal correlations on cohort size and present some simple statistical techniques for determining cohort sizes that may be helpful in designing preclinical imaging studies. We describe studies that are greatly facilitated by access to non-invasive imaging data including a study involving multiple endpoints and another investigating metastasis. We conclude with a brief survey of emerging approaches in small-animal PET imaging.
引用
收藏
页码:137 / 149
页数:13
相关论文
共 61 条
  • [1] PET imaging of development and malignant transformation in a mouse model of mammary intraepithelial neoplasia
    Abbey, CK
    Borowsky, AD
    McGoldrick, ET
    Gregg, JP
    Cardiff, RD
    Cherry, SR
    [J]. Medical Imaging 2005: Physiology, Function, and Structure From Medical Images, Pts 1 and 2, 2005, 5746 : 1 - 8
  • [2] In vivo positron of progression-emission tomography imaging of progression and transformation in model of mammary neoplasia
    Abbey, CK
    Borowsky, AD
    McGoldrick, ET
    Gregg, JP
    Maglione, JE
    Cardiff, RD
    Cherry, SR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (31) : 11438 - 11443
  • [3] Molecular characterization of the tumor microenvironment in breast cancer
    Allinen, M
    Beroukhim, R
    Cai, L
    Brennan, C
    Lahti-Domenici, J
    Huang, HY
    Porter, D
    Hu, M
    Chin, L
    Richardson, A
    Schnitt, S
    Sellers, WR
    Polyak, K
    [J]. CANCER CELL, 2004, 6 (01) : 17 - 32
  • [4] [Anonymous], 2002, ANAL LONGITUDINAL DA
  • [5] BAILEY DL, 2005, POSITRON EMISSION TO
  • [6] Barthel H, 2003, CANCER RES, V63, P3791
  • [7] Assessment of hypoxia in experimental mice tumours by [18F]fluoromisonidazole PET and pO2 electrode measurements -: Infuence of tumour volume and carbogen breathing
    Bentzen, L
    Keiding, S
    Horsman, MR
    Grönroos, T
    Hansen, SB
    Overgaard, J
    [J]. ACTA ONCOLOGICA, 2002, 41 (03) : 304 - 312
  • [8] The TOR pathway: A target for cancer therapy
    Bjornsti, MA
    Houghton, PJ
    [J]. NATURE REVIEWS CANCER, 2004, 4 (05) : 335 - 348
  • [9] Syngeneic mouse mammary carcinoma cell lines: Two closely related cell lines with divergent metastatic behavior
    Borowsky, AD
    Namba, R
    Young, LJT
    Hunter, KW
    Hodgson, JG
    Tepper, CG
    McGoldrick, ET
    Muller, WJ
    Cardiff, R
    Gregg, JP
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2005, 22 (01) : 47 - 58
  • [10] Brown RS, 1996, J NUCL MED, V37, P1042